These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 7362880)
1. Antitumoral activity of dipyrido [4,3-b] [3,4-f] indoles on L 1210 leukemia. Lidereau R; Chermann JC; Gruest J; Montagnier L; Ducrocq C; Rivalle C; Bisagni E Bull Cancer; 1980; 67(1):1-8. PubMed ID: 7362880 [TBL] [Abstract][Full Text] [Related]
2. Intercalative binding to DNA of new antitumoral agents: dipyrido [4,3-b] [3,4-f] indoles. Tourbez-Perrin M; Pochon F; Ducrocq C; Rivalle C; Bisagni E Bull Cancer; 1980; 67(1):9-13. PubMed ID: 7362892 [TBL] [Abstract][Full Text] [Related]
3. [Cytotoxic and antitumor activity of a new series of heterocyclic compounds: dipyrido (4,3-b) (3,4-f) indoles]. Chermann JC; Gruest J; Montagnier L; Wendling F; Tambourin P; Perrin M; Pochon F; Ducrocq C; Rivalle C; Bisagni E C R Acad Hebd Seances Acad Sci D; 1977 Oct; 285(8):945-8. PubMed ID: 410562 [TBL] [Abstract][Full Text] [Related]
4. Biological properties of 5,11-dimethyl-6H-pyrido[3,2-b]carbazoles: a new class of potent antitumour drugs. Moinet-Hedin V; Tabka T; Poulain L; Godard T; Lechevrel M; Saturnino C; Lancelot JC; Le Talaër JY; Gauduchon P Anticancer Drug Des; 2000 Apr; 15(2):109-18. PubMed ID: 10901298 [TBL] [Abstract][Full Text] [Related]
5. 1-Amino-substituted 8-hydroxy-4,5-dimethyl-5H-pyrido[4,3-b]indoles with propyl- or methyl substituents at the 9-, and 7,9-positions: synthesis and biological evaluation. Costache E; Nguyen CH; Léonce S; Pierré A; Atassi G; Bisagni E Anticancer Drug Des; 1998 Jun; 13(4):361-72. PubMed ID: 9627673 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of selenium on the growth of L1210 leukemic cells. Milner JA; Hsu CY Cancer Res; 1981 May; 41(5):1652-6. PubMed ID: 7214335 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, properties and biological evaluation of substituted furo[3,2-e] and pyrano[3,2-e]pyrido[4,3-b]indoles. Costache E; Nguyen CH; Guilbaud N; Léonce S; Pierré A; Atassi G; Bisagni E Anticancer Drug Des; 1998 Jun; 13(4):373-86. PubMed ID: 9627674 [TBL] [Abstract][Full Text] [Related]
8. [Modulation of the antitumor activity of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosoure a by O(6)-methyl-2'-deoxyguanosine--a new inhibitor of O(6)-alkylguanine-DNA-alkyltransferase]. Dederer LIu; Sokolova IS; Bakhmedova AA; Miniker TD; Mel'nik SIa; Gorbacheva LB Biokhimiia; 1995 Sep; 60(9):1521-9. PubMed ID: 8562657 [TBL] [Abstract][Full Text] [Related]
9. Antitumor amino-substituted pyrido[3',4':4,5]pyrrolo[2,3-g]isoquinolines and pyrido[4,3-b]carbazole derivatives: synthesis and evaluation of compounds resulting from new side chain and heterocycle modifications. Rivalle C; Wendling F; Tambourin P; Lhoste JM; Bisagni E; Chermann JC J Med Chem; 1983 Feb; 26(2):181-5. PubMed ID: 6827534 [TBL] [Abstract][Full Text] [Related]
10. Intoplicine (RP 60475) and its derivatives, a new class of antitumor agents inhibiting both topoisomerase I and II activities. Riou JF; Fossé P; Nguyen CH; Larsen AK; Bissery MC; Grondard L; Saucier JM; Bisagni E; Lavelle F Cancer Res; 1993 Dec; 53(24):5987-93. PubMed ID: 8261412 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of new 1-phenyl-6H-pyrido[4,3-b]carbazole derivatives with potential cytostatic activity. Tylińska B; Jasztold-Howorko R; Mastalarz H; Szczaurska-Nowak K; Materek P; Wietrzyk J Acta Pol Pharm; 2011; 68(1):31-7. PubMed ID: 21485699 [TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of DL-threo-beta-fluoroasparagine against human leukemia cells in culture and L1210 cells in DBA mice. Stern AM; Abeles RH; Tashjian AH Cancer Res; 1984 Dec; 44(12 Pt 1):5614-8. PubMed ID: 6498822 [TBL] [Abstract][Full Text] [Related]
13. The effect of dose interval on the survival of L1210 leukemic mice treated with DNA synthesis inhibitors. Neil GL; Homan ER Cancer Res; 1973 Apr; 33(4):895-901. PubMed ID: 4696483 [No Abstract] [Full Text] [Related]
14. Synthesis, structure, and cytostatic properties of new olivacine derivatives. Jasztold-Howorko R; Croisy A; Carrez D; Jaroszewicz I; Nasulewicz A; Pełczyńska M; Opolski A Arch Pharm (Weinheim); 2004 Nov; 337(11):599-604. PubMed ID: 15543533 [TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of novel octalactin A analogs in murine leukemia cells in vitro. Perchellet JP; Perchellet EM; Newell SW; Freeman JA; Ladesich JB; Jeong Y; Sato N; Buszek K Anticancer Res; 1998; 18(1A):97-106. PubMed ID: 9568062 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of 4-amino-substituted 7-methoxy (and 7-hydroxy)- 11-methyl (and 5,11-dimethyl)-10H-pyrido [2,3-b] carbazoles and 4-amino- substituted 11-methyl (and 5,11-dimethyl)-10H-pyrido[3',4':4,5] pyrrolo [3,2-g] quinolines, two new series related to antitumor ellipticine derivatives. Moron J; Rautureau M; Huel C; Pierré A; Berthier LK; Atassi G; Bisagni E Anticancer Drug Des; 1993 Dec; 8(6):399-416. PubMed ID: 8286009 [TBL] [Abstract][Full Text] [Related]